AVTR
Avantor, Inc. NYSE Listed May 17, 2019$9.58
+1.27%
vs $9.46
Mkt Cap $6.5B
52w Low $7.41
26.5% of range
52w High $15.60
50d MA $8.50
200d MA $10.52
P/E (TTM)
-12.3x
EV/EBITDA
72.5x
P/B
1.2x
Debt/Equity
0.7x
ROE
-9.9%
P/FCF
13.1x
RSI (14)
57.30
ATR (14)
$0.43
Beta
1.00
50d MA
$8.50
200d MA
$10.52
Avg Volume
10.1M
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Radnor Corporate Center · Radnor, PA 19087 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | TNS | 0.16 | 0.17 | +6.2% | 7.85 | +0.1% | +3.2% | -1.7% | +0.4% | +0.8% | +4.7% | — |
| Feb 11, 2026 | TNS | 0.21 | 0.22 | +4.8% | 9.64 | -1.5% | -5.2% | +0.7% | -1.6% | +2.4% | -0.6% | — |
| Oct 29, 2025 | TNS | 0.22 | 0.22 | -2.1% | 11.58 | -2.2% | -4.6% | +7.0% | -1.2% | -0.9% | +0.0% | — |
| Aug 1, 2025 | TNS | 0.25 | 0.24 | -4.0% | 11.36 | +0.4% | -0.5% | +3.0% | -4.0% | +1.8% | +1.1% | — |
| Apr 25, 2025 | TNS | 0.23 | 0.23 | -0.6% | 12.93 | -0.1% | -3.4% | +1.6% | +2.4% | -0.2% | -0.7% | — |
| Feb 7, 2025 | TNS | 0.25 | 0.27 | +8.0% | 19.16 | +1.8% | -0.8% | -3.3% | -1.8% | +0.3% | -1.3% | — |
| Oct 25, 2024 | TNS | 0.25 | 0.26 | +2.1% | 22.43 | +1.5% | +0.9% | -0.5% | -0.3% | -0.4% | -0.3% | — |
| Jul 26, 2024 | TNS | 0.23 | 0.25 | +7.6% | 25.60 | -0.2% | +2.5% | +5.3% | -3.3% | -0.9% | -3.4% | — |
| Apr 26, 2024 | TNS | 0.20 | 0.22 | +9.5% | 23.94 | -0.4% | +0.6% | +0.6% | +0.8% | -0.4% | +1.6% | — |
| Feb 14, 2024 | TNS | 0.22 | 0.25 | +13.6% | 24.40 | +0.0% | -1.4% | -1.2% | +1.2% | +1.5% | +0.7% | — |
| Oct 27, 2023 | TNS | 0.25 | 0.25 | +0.0% | 17.83 | +0.6% | -3.8% | +1.6% | -0.1% | +4.5% | +0.9% | — |
| Jul 28, 2023 | TNS | 0.29 | 0.28 | -3.4% | 21.28 | -1.4% | -3.3% | +1.6% | +0.6% | -2.0% | +0.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2 | Wolfe Research | Reiterates | Underperform | $7 | $9.19 | $8.79 | -4.4% | -2.2% | +0.9% | +5.0% | -3.8% | +5.8% |
| May 15 | RBC Capital Mkts | Reiterates | Sector Perform | $9 | $7.94 | $7.92 | -0.3% | -4.0% | -0.3% | +0.5% | +3.1% | -0.1% |
| Apr 30 | Evercore ISI | Maintains | In Line → In Line | — | $7.85 | $7.86 | +0.1% | +3.2% | -1.7% | +0.4% | +0.8% | +4.7% |
| Apr 30 | Citigroup | Maintains | Neutral → Neutral | — | $7.85 | $7.86 | +0.1% | +3.2% | -1.7% | +0.4% | +0.8% | +4.7% |
| Apr 15 | Barclays | Maintains | Underweight → Underweight | — | $8.20 | $8.28 | +1.0% | +2.1% | -1.3% | +3.1% | -0.2% | +0.4% |
| Apr 6 | Evercore ISI | Maintains | In Line → In Line | — | $7.90 | $7.78 | -1.5% | +1.0% | +0.3% | +0.0% | -1.0% | -0.3% |
| Mar 6 | Barclays | Downgrade | Equal Weight → Underweight | — | $8.52 | $8.26 | -3.1% | -4.1% | -0.2% | +0.0% | +1.7% | -4.7% |
| Feb 13 | Wells Fargo | Maintains | Overweight → Overweight | — | $9.14 | $9.52 | +4.2% | +0.7% | -1.6% | +2.4% | -0.6% | -2.0% |
| Feb 12 | Barclays | Maintains | Equal Weight → Equal Weight | — | $9.64 | $9.50 | -1.5% | -5.2% | +0.7% | -1.6% | +2.4% | -0.6% |
| Feb 12 | Citigroup | Maintains | Neutral → Neutral | — | $9.64 | $9.50 | -1.5% | -5.2% | +0.7% | -1.6% | +2.4% | -0.6% |
| Jan 7 | TD Cowen | Maintains | Hold → Hold | — | $12.27 | $12.25 | -0.2% | -1.5% | -0.2% | +2.9% | -1.0% | +2.6% |
| Jan 5 | Evercore ISI | Downgrade | Outperform → In Line | — | $11.46 | $11.28 | -1.6% | +3.8% | +3.2% | -1.5% | -0.2% | +2.9% |
| Dec 17 | Jefferies | Downgrade | Hold → Underperform | — | $11.20 | $10.96 | -2.1% | -0.9% | -0.3% | +1.8% | -0.3% | +0.3% |
| Oct 30 | JP Morgan | Downgrade | Overweight → Neutral | — | $11.58 | $11.33 | -2.2% | -4.6% | +7.0% | -1.2% | -0.9% | +0.0% |
| Oct 30 | Evercore ISI | Maintains | Outperform → Outperform | — | $11.58 | $11.33 | -2.2% | -4.6% | +7.0% | -1.2% | -0.9% | +0.0% |
| Oct 30 | Barclays | Downgrade | Overweight → Equal Weight | — | $11.58 | $11.33 | -2.2% | -4.6% | +7.0% | -1.2% | -0.9% | +0.0% |
| Oct 24 | Baird | Maintains | Outperform → Outperform | — | $15.46 | $15.61 | +1.0% | -0.4% | -1.9% | -0.2% | -23.2% | -4.6% |
| Oct 16 | Raymond James | Maintains | Outperform → Outperform | — | $13.87 | $14.10 | +1.7% | +5.0% | +1.4% | +2.7% | +2.8% | -2.8% |
| Oct 2 | Barclays | Maintains | Overweight → Overweight | — | $13.67 | $13.71 | +0.3% | +0.7% | +3.8% | -1.4% | -4.4% | +2.1% |
| Aug 4 | JP Morgan | Maintains | Overweight → Overweight | — | $11.36 | $11.41 | +0.4% | -0.5% | +3.0% | -4.0% | +1.8% | +1.1% |
| Aug 4 | Stifel | Maintains | Hold → Hold | — | $11.36 | $11.41 | +0.4% | -0.5% | +3.0% | -4.0% | +1.8% | +1.1% |
| Aug 4 | Barclays | Maintains | Overweight → Overweight | — | $11.36 | $11.41 | +0.4% | -0.5% | +3.0% | -4.0% | +1.8% | +1.1% |
| Aug 4 | Raymond James | Maintains | Outperform → Outperform | — | $11.36 | $11.41 | +0.4% | -0.5% | +3.0% | -4.0% | +1.8% | +1.1% |
| Aug 4 | Wells Fargo | Maintains | Overweight → Overweight | — | $11.36 | $11.41 | +0.4% | -0.5% | +3.0% | -4.0% | +1.8% | +1.1% |
| Aug 4 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $11.36 | $11.41 | +0.4% | -0.5% | +3.0% | -4.0% | +1.8% | +1.1% |
| Aug 4 | Evercore ISI | Maintains | Outperform → Outperform | — | $11.36 | $11.41 | +0.4% | -0.5% | +3.0% | -4.0% | +1.8% | +1.1% |
| Aug 4 | RBC Capital | Maintains | Outperform → Outperform | — | $11.36 | $11.41 | +0.4% | -0.5% | +3.0% | -4.0% | +1.8% | +1.1% |
| Aug 4 | Baird | Maintains | Outperform → Outperform | — | $11.36 | $11.41 | +0.4% | -0.5% | +3.0% | -4.0% | +1.8% | +1.1% |
| Jul 28 | Baird | Maintains | Outperform → Outperform | — | $14.21 | $14.30 | +0.6% | -1.5% | +0.1% | -1.5% | -2.6% | -15.5% |
| Apr 29 | Goldman Sachs | Downgrade | Buy → Neutral | — | $12.49 | $12.41 | -0.6% | +1.6% | +2.4% | -0.2% | -0.7% | -1.9% |
| Apr 28 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $12.93 | $12.92 | -0.1% | -3.4% | +1.6% | +2.4% | -0.2% | -0.7% |
| Apr 28 | Stifel | Downgrade | Buy → Hold | — | $12.93 | $12.92 | -0.1% | -3.4% | +1.6% | +2.4% | -0.2% | -0.7% |
| Apr 28 | Baird | Maintains | Outperform → Outperform | — | $12.93 | $12.92 | -0.1% | -3.4% | +1.6% | +2.4% | -0.2% | -0.7% |
| Apr 28 | RBC Capital | Maintains | Outperform → Outperform | — | $12.93 | $12.92 | -0.1% | -3.4% | +1.6% | +2.4% | -0.2% | -0.7% |
| Apr 28 | Barclays | Maintains | Overweight → Overweight | — | $12.93 | $12.92 | -0.1% | -3.4% | +1.6% | +2.4% | -0.2% | -0.7% |
| Apr 17 | Wells Fargo | Maintains | Overweight → Overweight | — | $15.25 | $15.17 | -0.5% | -1.0% | -0.9% | +2.1% | +1.2% | +0.2% |
| Apr 10 | Barclays | Maintains | Overweight → Overweight | — | $15.89 | $15.42 | -3.0% | -7.5% | +3.5% | +2.2% | -1.0% | -1.0% |
| Mar 4 | Citigroup | Maintains | Neutral → Neutral | — | $15.87 | $15.70 | -1.1% | -2.3% | +1.6% | +2.7% | +8.2% | -1.3% |
| Feb 10 | RBC Capital | Maintains | Outperform → Outperform | — | $19.16 | $19.50 | +1.8% | -0.8% | -3.3% | -1.8% | +0.3% | -1.3% |
| Feb 10 | Barclays | Maintains | Overweight → Overweight | — | $19.16 | $19.50 | +1.8% | -0.8% | -3.3% | -1.8% | +0.3% | -1.3% |
| Feb 10 | Wells Fargo | Maintains | Overweight → Overweight | — | $19.16 | $19.50 | +1.8% | -0.8% | -3.3% | -1.8% | +0.3% | -1.3% |
| Feb 10 | Stifel | Maintains | Buy → Buy | — | $19.16 | $19.50 | +1.8% | -0.8% | -3.3% | -1.8% | +0.3% | -1.3% |
| Feb 10 | Morgan Stanley | Maintains | Overweight → Overweight | — | $19.16 | $19.50 | +1.8% | -0.8% | -3.3% | -1.8% | +0.3% | -1.3% |
| Feb 10 | Raymond James | Maintains | Outperform → Outperform | — | $19.16 | $19.50 | +1.8% | -0.8% | -3.3% | -1.8% | +0.3% | -1.3% |
| Feb 3 | Barclays | Maintains | Overweight → Overweight | — | $22.28 | $21.94 | -1.5% | -1.8% | +0.6% | -0.1% | -1.3% | -11.7% |
| Jan 21 | Raymond James | Maintains | Outperform → Outperform | — | $22.11 | $22.23 | +0.5% | -1.5% | +1.5% | -1.0% | +0.9% | +1.9% |
| Jan 17 | UBS | Downgrade | Buy → Neutral | — | $22.57 | $22.21 | -1.6% | -2.0% | -1.5% | +1.5% | -1.0% | +0.9% |
| Oct 28 | Wells Fargo | Maintains | Overweight → Overweight | — | $22.43 | $22.77 | +1.5% | +0.9% | -0.5% | -0.3% | -0.4% | -0.3% |
| Oct 28 | Baird | Maintains | Outperform → Outperform | — | $22.43 | $22.77 | +1.5% | +0.9% | -0.5% | -0.3% | -0.4% | -0.3% |
| Oct 25 | Barclays | Maintains | Overweight → Overweight | — | $23.27 | $22.65 | -2.7% | -3.6% | +0.9% | -0.5% | -0.3% | -0.4% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2026 | LUCIER GREGORY TDir | — | Buy | 10,000 | $8.32 | $83K | 60,000 | +2.51% | -0.26% |
| May 1, 2026 | Dingemans SimonDir | — | Buy | 25,000 | $8.14 | $204K | 25,000 | +4.72% | +2.51% |
8-K
Avantor, Inc. -- 8-K Filing
May 12
8-K
Avantor, Inc. -- 8-K Filing
Avantor maintained its full-year 2026 guidance despite generating $25 million in cash flow during Q1, suggesting management confidence in operational performance amid ongoing execution.
Apr 29
8-K · 5.02
!!! Very High
Avantor, Inc. -- 8-K 5.02: Executive Change
Avantor appointed Ludovic Brellier as Executive Vice President, expanding its leadership team to strengthen operational oversight and strategic execution.
Apr 23
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A new CFO with GE and industrial manufacturing experience joins Avatars, potentially signaling improved financial controls and credibility with investors in capital-intensive operations.
Apr 1
8-K · 5.02
!!! Very High
Avantor, Inc. -- 8-K 5.02: Executive Change
Avantor appointed Sanjeev Mehra as a director effective December 4, 2025, expanding its board composition and potentially bringing new expertise to the life sciences services company's governance.
Feb 25
8-K · 5.02
!!! Very High
Avantor, Inc. -- 8-K 5.02: Executive Change
Avantor appoints Simon Dingemans as director effective January 2, 2026, potentially strengthening board oversight of the life sciences and materials supplier.
Feb 25
8-K · 7.01
! Medium
Avantor, Inc. -- 8-K 7.01: Regulation FD Disclosure
Avantor issued a press release on February 11, 2026, disclosing material information to investors under Regulation FD requirements.
Feb 11
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Dodge & Cox | 119,648,329 | $938M | Added | Mar 2026 |
| 2 | Morgan Stanley | 34,936,836 | $400M | Added | Dec 2025 |
| 3 | Vanguard Portfolio Management Llc | 31,275,847 | $245M | New | Mar 2026 |
| 4 | Vanguard Capital Management Llc | 30,606,112 | $240M | New | Mar 2026 |
| 5 | Greenhaven Associates Inc | 22,593,838 | $177M | Added | Mar 2026 |
| 6 | Barrow Hanley Mewhinney & Strauss Llc | 22,358,399 | $175M | Reduced | Mar 2026 |
| 7 | New Mountain Capital, L.l.c. | 14,000,000 | $160M | — | Dec 2025 |
| 8 | D.e. Shaw & Co | 13,110,674 | $103M | Added | Mar 2026 |
| 9 | London Co Of Virginia | 10,852,257 | $85M | Reduced | Mar 2026 |
| 10 | Clarkston Capital Partners, Llc | 8,629,389 | $68M | Reduced | Mar 2026 |
| 11 | First Pacific Advisors, Lp | 8,089,023 | $63M | Added | Mar 2026 |
| 12 | Invesco Ltd. | 8,073,854 | $63M | Reduced | Mar 2026 |
| 13 | Fmr Llc | 7,610,318 | $60M | Reduced | Mar 2026 |
| 14 | Voya Investment Management Llc | 4,961,474 | $57M | — | Dec 2025 |
| 15 | Bank Of America Corp /de/ | 7,067,563 | $55M | Added | Mar 2026 |
| 16 | Jane Street Group, Llc | 3,831,817 | $44M | Added | Dec 2025 |
| 17 | Northern Trust Corp | 5,458,656 | $43M | Added | Mar 2026 |
| 18 | Sei Investments Co | 5,287,850 | $41M | Added | Mar 2026 |
| 19 | Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main | 1,560,003 | $40M | Reduced | Sep 2024 |
| 20 | Aqr Capital Management Llc | 4,867,208 | $38M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$6.51B
Enterprise Value
$10.06B
P/E (TTM)
-12.28x
Forward P/E
12.21x
PEG Ratio
0.08x
P/B
1.17x
P/S
0.99x
P/FCF
13.15x
EV/EBITDA
72.51x
Shares Out
679.3M
Financials (TTM)
Revenue
$6.55B
Net Income
-$530.2M
EBITDA
$138.7M
Free Cash Flow
$495.0M
Op Cash Flow
$623.8M
EPS Basic
$-0.78
EPS Diluted
$-0.78
EPS Forward
$0.78
Gross Margin
32.6%
Op Margin
-3.8%
Net Margin
-8.1%
Balance Sheet
Total Assets
$11.79B
Total Liab.
$6.23B
Total Equity
$5.57B
Cash
$365.4M
LT Debt
$3.92B
Book Value/Sh
$8.21
Debt/Equity
0.71x
Current Ratio
1.78
Quick Ratio
1.18
Returns & Growth
ROE
-9.9%
ROA
-4.7%
ROIC
-2.4%
Rev Growth YoY
-3.4%
EPS Growth YoY
-174.3%
Price Returns
2W
+14.9%
1M
+12.6%
3M
+0.8%
6M
-22.3%
12M
-29.4%
Technicals
52W High
$15.60
52W Low
$7.41
50d MA
$8.50
200d MA
$10.52
RSI (14)
57.30
ATR (14)
$0.43
Beta
1.00
Avg Volume
10.1M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$9.50
High
$11.00
Low
$7.00
Median
$10.00
Data updated apr 24, 2026 8:04pm
· Source: financialmodelingprep.com